NIH-funded research Career grant

Understanding and treating anxiety in children with autism

Official title: Anxiety in Youth with Autism Spectrum Disorder

Funded at Massachusetts General Hospital · NIH-10924052 · Data updated 2026-11-12

This study is looking at how anxiety affects kids with autism and is testing a medication called buspirone to see if it can help reduce their anxiety symptoms, all while trying to understand how their bodies respond to treatment.

More Anxiety research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 7, 2023
Project endJanuary 19, 2026
Funding year2025
Award (this year)$128,724
NIH project number5K99MH135180-02
Project IDNIH-10924052 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years diagnosed with autism spectrum disorder who experience significant anxiety symptoms.

Less likely to help

Patients who do not have autism spectrum disorder or those without anxiety symptoms may not benefit from this research.

What this research studies

This research investigates anxiety disorders in youth with autism spectrum disorder (ASD), focusing on identifying biological markers that correlate with anxiety severity. The study aims to conduct a clinical trial to evaluate the effectiveness of buspirone, a medication, in reducing anxiety symptoms in these children. By utilizing advanced measures of the autonomic nervous system, the research seeks to uncover the mechanisms behind treatment responses. This approach is designed to improve the quality of care for youth with ASD who struggle with anxiety.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for anxiety in children with autism, improving their overall quality of life.

How similar studies have gone: Previous research has shown that innovative approaches to treating anxiety in youth with ASD can lead to meaningful advancements, although this specific trial represents a novel effort.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Thom, Robyn P. — Massachusetts General Hospital
  • Study coordinator: Thom, Robyn P.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.